The bleeding time test can aid in the diagnostic evaluation of patients with clinical hemorrhagic disorders or a history of bleeding. However, its low positive predictive value in predicting perioperative bleeding should force one to abandon it as a routine preoperative screening test.
INa'iiV Ji J Many methodologic factors affect the bleeding time, including the length, depth, orientation, and location of the incision and whether a blood pressure cuff is used. The bleeding time also varies with age, sex, blood group, medication use, skin characteristics, and diet.
A prolonged bleeding time itself is nonspecific and is not pathognomonic of a single disease entity.
Many studies have shown no association between a prolonged preoperative bleeding time and increased perioperative blood loss.
Even though a prolonged preoperative bleeding time usually lacks clinical significance, it often leads to additional laboratory tests, postponement of surgery, increased length of stay, and possibly inappropriate treatment.
T
HE BLEEDING TIME is the most commonly used test in the in vivo evaluation of primary hemostasis. Although this test is known for its role in the evaluation of patients suspected of having von Willebrand's disease or abnormal platelet function, it is quite often routinely ordered as part of preoperative screening to predict perioperative bleeding in patients with no previous clinical signs of a bleeding disorder. Physicians should be familiar with factors that affect the standardization, reliability and specificity of the bleeding time test, as well as the pitfalls of using it to predict clinically significant perioperative bleeding.
The bleeding time test was first described by Milian 
MULTIPLE FACTORS AFFECT THE BLEEDING TIME
Despite these improvements and modifications, the bleeding time test continues to be prone to many technical problems that interfere with its standardization and reliability. Many factors affect the reproducibility of the bleeding time. Test results are highly operator-dependent, with significant interoperator variability. 6 This reflects the technical difficulties inherent in the test methodology: the length, depth, orientation (vertical vs horizontal), and location (volar aspect of the forearm vs antecubital fossa) of the incision can all affect the results, as can the use of a blood pressure cuff and the characteristics of the skin (thickness, degree of underlying vascularity, and density of hair). 7, 8 Although the introduction of a spring-loaded device has standardized the length and depth of the incision to some extent, the other variables remain, making it difficult to derive a valid and clinically useful bleeding time.
The bleeding time also varies with age, sex, blood group, medication use, and diet. 9 
THE BLEEDING TIME AS A PREOPERATIVE SCREENING TEST
Approximately half of the 1 to 2 million bleeding time tests performed each year are ordered as part of a preoperative evaluation to assess perioperative bleeding risk. 23 The clinical use of the bleeding time in this fashion implies the acceptance of at least two assumptions. The first is that superficial bleeding of the skin accurately reflects the potential for bleeding at other sites. However, O'Laughlin et al 24 evaluated the effect of short-term and long-term aspirin use in patients undergoing gastric biopsy and found no evidence that an increased skin bleeding time reflected an increased gastric bleeding time.
The second assumption is that prolongation of the bleeding time is clinically significant. Many studies and reviews that examined this question have demonstrated that the predictive value of the preoperative bleeding time is poor. 25 time, there was no statistically significant association between an abnormal bleeding time and perioperative bleeding or use of blood products. The positive predictive value of the routine preoperative bleeding time for predicting perioperative bleeding was only 5%. 28 The association between platelet dysfunction and perioperative blood loss has been investigated in a variety of surgical settings. Owing to the use of cardiopulmonary bypass, cardiovascular procedures have a deleterious effect on platelets, and perioperative bleeding has been extensively investigated in this patient population. Simon et al 29 The most extensive study in noncardiac surgery was a retrospective one by Barber et al. 34 Of 1941 patients, 110 (5.7%) had abnormal preoperative bleeding times. Of these patients, 58 subsequently underwent surgery, and only six (10.3%) lost more than 500 mL of blood. 34 Other studies involving general surgery, emergency surgery, tonsillectomy, middle ear surgery, and cataract surgery support the conclusion that a prolonged bleeding time does not correlate with clinically significant perioperative bleeding. 35 " 39 Not infrequently, surgical patients have been taking medications that can impair platelet function. The possibility of perioperative bleeding in such patients is often of clinical concern and often leads to the ordering of a bleeding time test. However, in a study of patients who were given aspirin before undergoing total hip replacement, Amrein 40 found that the bleeding time was prolonged, but perioperative bleeding was not increased. In another study, Ferraris and Swanson 36 found that only eight of 22 patients who had taken aspirin within 72 hours of an unplanned surgical procedure had prolonged bleeding times, but neither a prolonged bleeding time nor aspirin ingestion was associated with increased perioperative bleeding. For patients undergoing cardiopulmonary bypass, administration of aspirin within 12 hours of CABG was not associated with increased postoperative bleeding, but bleeding time data were not obtained. 41 Gewirtz et al 28 An abnormal bleeding time presents the laboratory, clinician, and hospital with many problematic issues, all of which contribute to increased utilization of resources and higher health care costs. The far-reaching effects of an abnormal result can, depending on the situation, include the ordering of additional laboratory tests, postponement of surgery, increased length of stay, and, possibly, inappropriate treatment with blood products and drugs (in particular desmopressin acetate) in an attempt to normalize the bleeding time. In addition to these added costs, each of the 500 000 to 1 million preoperative bleeding time tests performed each year costs approximately $30, resulting in an annual cost of $15 to $30 million.
CONCLUSION
Given the low positive predictive value of the preoperative bleeding time and the need to reduce health care spending where possible, the bulk of the evidence demands that the bleeding time be abandoned as a preoperative screening test.
